Anika Therapeutics ANIK Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's deferred tax assets and other non-current assets?
- Anika Therapeutics (ANIK) reported deferred tax assets and other non-current assets of $4.3M in Q1 2026.
- How has Anika Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Anika Therapeutics's deferred tax assets and other non-current assets decreased by 24.8% year-over-year, from $5.73M to $4.3M.
- What is the long-term trend for Anika Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Anika Therapeutics's deferred tax assets and other non-current assets has grown at a -23.5% compound annual growth rate (CAGR), from $15.42M to $4.03M.